CoChat

The In Vivo Fibrotic Role of FIZZ1 in Pulmonary Fibrosis

Open access
Liu, Tianju, Yu, Hongfeng, Ullenbruch, Matthew, Jin, Hong, Ito, Toshihiro, Wu, Zhe, Liu, Jianhua, Phan, Sem H. · 2014 · PLoS ONE

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

FIZZ (found in inflammatory zone) 1, a member of a cysteine-rich secreted protein family, is highly induced in lung allergic inflammation and bleomycin induced lung fibrosis, and primarily expressed by airway and type II alveolar epithelial cells. This novel mediator is known to stimulate α-smooth muscle actin and collagen expression in lung fibroblasts. The objective of this study was to investigate the in vivo effects of FIZZ1 on the development of lung fibrosis by evaluating bleomycin-induced pulmonary fibrosis in FIZZ1 deficient mice. FIZZ1 knockout mice exhibited no detectable abnormality. When these mice were treated with bleomycin they exhibited significantly impaired pulmonary fibrosis relative to wild type mice, along with impaired proinflammatory cytokine/chemokine expression. Deficient lung fibroblast activation was also noted in the FIZZ1 knockout mice. Moreover, recruitment of bone marrow-derived cells to injured lung was deficient in FIZZ1 knockout mice. Interestingly in vitro FIZZ1 was shown to have chemoattractant activity for bone marrow cells, including bone marrow-derived dendritic cells. Finally, overexpression of FIZZ1 exacerbated fibrosis. These findings suggested that FIZZ1 exhibited profibrogenic properties essential for bleomycin induced pulmonary fibrosis, as reflected by its ability to induce myofibroblast differentiation and recruit bone marrow-derived cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0088362

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Generation of FIZZ1 KO mice. (A) Gene targeting strategy and restriction map of FIZZ1 gene. The diagram showed the wild type FIZZ1 gene allele and the gene targeted allele. The black boxes E1–E4 represent the four exons of FIZZ1 gene. All four exons of the FIZZ1 gene were replaced by a Neo gene cassette. (B) Southern blotting analysis of an ES cell clone with homologous recombination. A 3′ probe (shown in A) was used to detect 26 kb WT and 10 kb KO alleles. (C) PCR genotype using mouse tail DNA from wild type (“WT”), FIZZ1 heterozygote (“Het”) and homozygous knockout (“KO”) mice. The PCR fragment for WT was 525 bp, and KO was 351 bp. “Lad” referred to 100 bp ladder.
Figure 1 Generation of FIZZ1 KO mice. (A) Gene targeting strategy and restriction map of FIZZ1 gene. The diagram showed the wild type FIZZ1 gene allele and the gene targeted allele. The black boxes E1–E4 represent the four exons of FIZZ1 gene. All four exons of the FIZZ1 gene were replaced by a Neo gene cassette. (B) Southern blotting analysis of an ES cell clone with homologous recombination. A 3′ probe (shown in A) was used to detect 26 kb WT and 10 kb KO alleles. (C) PCR genotype using mouse tail DNA from wild type (“WT”), FIZZ1 heterozygote (“Het”) and homozygous knockout (“KO”) mice. The PCR fragment for WT was 525 bp, and KO was 351 bp. “Lad” referred to 100 bp ladder.CC BY · PubMed Central
Figure 2 Construction of AdFIZZ1. AdCMVFIZZ1.dlE3 was generated by inserting a 500-LoxP recombination between shuttle vector and the cAd5-deltaE3.LoxP cosmid. Rat FIZZ1 cDNA was under CMV promoter. “ITR” referred to the Ad5ITR and Packaging signal.
Figure 2 Construction of AdFIZZ1. AdCMVFIZZ1.dlE3 was generated by inserting a 500-LoxP recombination between shuttle vector and the cAd5-deltaE3.LoxP cosmid. Rat FIZZ1 cDNA was under CMV promoter. “ITR” referred to the Ad5ITR and Packaging signal.CC BY · PubMed Central
Figure 3 Effects of FIZZ1 deficiency on BLM-induced pulmonary fibrosis. WT control or FIZZ1 KO mice were treated with PBS (CON) or BLM as indicated. The lungs were harvested at day 21, and analyzed for lung HYP content (A). The values were expressed as percentages of their respective PBS control. Data were shown as mean ± SE with 5 mice in each group. *P<0.05 or **P<0.001 compared to control. Type I collagen, α-SMA and mRNA and protein in the lungs were also analyzed by qPCR (B) and Western blotting (C), respectively. A typical blot from 5 mice in each group was shown. The lung RNA from day 7 after PBS (CON) or BLM treatment was also analyzed for cytokines mRNA expression by qPCR (D). Results were expressed as 2−ΔΔCT. The values were expressed as percentages of their respective PBS control. The numbers of total BAL cell (E) and BAL macrophage/monocyte (F) were counted at day 7 of BLM or PBS treated WT or FIZZ1 KO mice. Data were shown as mean ± SE (n = 7 mice for total BAL cell, 4 mice for macrophage/monocyte).
Figure 3 Effects of FIZZ1 deficiency on BLM-induced pulmonary fibrosis. WT control or FIZZ1 KO mice were treated with PBS (CON) or BLM as indicated. The lungs were harvested at day 21, and analyzed for lung HYP content (A). The values were expressed as percentages of their respective PBS control. Data were shown as mean ± SE with 5 mice in each group. *P<0.05 or **P<0.001 compared to control. Type I collagen, α-SMA and mRNA and protein in the lungs were also analyzed by qPCR (B) and Western blotting (C), respectively. A typical blot from 5 mice in each group was shown. The lung RNA from day 7 after PBS (CON) or BLM treatment was also analyzed for cytokines mRNA expression by qPCR (D). Results were expressed as 2−ΔΔCT. The values were expressed as percentages of their respective PBS control. The numbers of total BAL cell (E) and BAL macrophage/monocyte (F) were counted at day 7 of BLM or PBS treated WT or FIZZ1 KO mice. Data were shown as mean ± SE (n = 7 mice for total BAL cell, 4 mice for macrophage/monocyte).CC BY · PubMed Central
Figure 4 FIZZ1 effects on BM cell recruitment. (A) Fresh isolated whole BM cells from day 7 BLM (“BLM-BM”) or PBS (“CON-BM”) treated mice were preloaded with fluorescent dye, and then plated into 5 µm-inserts in 24-well transwell plates. After 2 hours of incubation with the indicated doses of FIZZ1 in the lower chambers, the cells that have migrated to the lower chambers were quantitated by measuring the fluorescence with an excitation and emission wavelengths of 494 and 517 nm, respectively. The results were normalized to the controls and expressed as percentages of controls, and shown as mean ± SE (n = 3). In (B) purified BM-derived DC from day 7 BLM (“BLM-BMDC”) or PBS (“CON-BMDC”) treated mice were similarly analyzed as in (A) for migration to media only (“None”) or to 50 ng/ml FIZZ1 in the lower chambers. The results were expressed as in (A). (C) BM from GFP transgenic mice were transplanted into WT or FIZZ1 KO mice to create GFP BM chimera mice of the respective recipient strain. After stable engraftment the mice were treated with BLM and 7 days later were analyzed for GFP expression in the lung cell population by flow cytometry. Three populations were discerned corresponding to the cells with undetectable (R1), low (R2) or high (R3) GFP fluorescence. One representative data was shown from two individual experiments, and the combined lung cells from two mice were used for flow cytometry in each group. Circulating FIZZ1 protein was measured in the sera (1∶50 dilution) by ELISA assay 21 days after BLM or PBS treatment (D). Results were shown as mean ± SE with 5–6 mice in each group. (E) Effect of FIZZ1 on migration of primary cultured mouse lung fibroblasts was also analyzed as described in legend for (A). *P<0.05 compared to control.
Figure 4 FIZZ1 effects on BM cell recruitment. (A) Fresh isolated whole BM cells from day 7 BLM (“BLM-BM”) or PBS (“CON-BM”) treated mice were preloaded with fluorescent dye, and then plated into 5 µm-inserts in 24-well transwell plates. After 2 hours of incubation with the indicated doses of FIZZ1 in the lower chambers, the cells that have migrated to the lower chambers were quantitated by measuring the fluorescence with an excitation and emission wavelengths of 494 and 517 nm, respectively. The results were normalized to the controls and expressed as percentages of controls, and shown as mean ± SE (n = 3). In (B) purified BM-derived DC from day 7 BLM (“BLM-BMDC”) or PBS (“CON-BMDC”) treated mice were similarly analyzed as in (A) for migration to media only (“None”) or to 50 ng/ml FIZZ1 in the lower chambers. The results were expressed as in (A). (C) BM from GFP transgenic mice were transplanted into WT or FIZZ1 KO mice to create GFP BM chimera mice of the respective recipient strain. After stable engraftment the mice were treated with BLM and 7 days later were analyzed for GFP expression in the lung cell population by flow cytometry. Three populations were discerned corresponding to the cells with undetectable (R1), low (R2) or high (R3) GFP fluorescence. One representative data was shown from two individual experiments, and the combined lung cells from two mice were used for flow cytometry in each group. Circulating FIZZ1 protein was measured in the sera (1∶50 dilution) by ELISA assay 21 days after BLM or PBS treatment (D). Results were shown as mean ± SE with 5–6 mice in each group. (E) Effect of FIZZ1 on migration of primary cultured mouse lung fibroblasts was also analyzed as described in legend for (A). *P<0.05 compared to control.CC BY · PubMed Central
Figure 5 Cytokine expression in BMDC. GM-CSF-induced BMDC were separated by MACS with anti-CD11c microbeads. IFNγ, FIZZ1 and MCP-1 were detected in two distinct cell populations. *P<0.05 vs. respective controls.
Figure 5 Cytokine expression in BMDC. GM-CSF-induced BMDC were separated by MACS with anti-CD11c microbeads. IFNγ, FIZZ1 and MCP-1 were detected in two distinct cell populations. *P<0.05 vs. respective controls.CC BY · PubMed Central
Figure 6 The lung HYP content was measured in GFP-FIZZ1 chimera lung samples after BLM or PBS treatment. Data were shown as percentages of their respective PBS controls. The mean values were shown from 2 mice each group. *P<0.05 vs. respective control values.
Figure 6 The lung HYP content was measured in GFP-FIZZ1 chimera lung samples after BLM or PBS treatment. Data were shown as percentages of their respective PBS controls. The mean values were shown from 2 mice each group. *P<0.05 vs. respective control values.CC BY · PubMed Central
Figure 7 AdFIZZ1 effects on lung fibrosis. The lung FIZZ1 mRNA (A) at the indicated time points and protein at day 21 (B) after AdFIZZ1 endotracheal administration alone, or with BLM injection (C) were analyzed by qPCR. The results were shown as mean ± SE of triplicate samples or animals. Type I collagen production in the lungs was analyzed at day 7 after indicated treatments with 200 ng lung tissue lysates by ELISA (D). Data were shown as mean ± SE with 5 samples in each group. Lung α-SMA mRNA at day 7 (E) and protein (F) after AdFIZZ1 injection with BLM or PBS were analyzed by qPCR or Western blotting, respectively. A representative blot was shown in (F).*P<0.05 compared to their respective controls. *P<0.05 or †P<0.001 compared to control.
Figure 7 AdFIZZ1 effects on lung fibrosis. The lung FIZZ1 mRNA (A) at the indicated time points and protein at day 21 (B) after AdFIZZ1 endotracheal administration alone, or with BLM injection (C) were analyzed by qPCR. The results were shown as mean ± SE of triplicate samples or animals. Type I collagen production in the lungs was analyzed at day 7 after indicated treatments with 200 ng lung tissue lysates by ELISA (D). Data were shown as mean ± SE with 5 samples in each group. Lung α-SMA mRNA at day 7 (E) and protein (F) after AdFIZZ1 injection with BLM or PBS were analyzed by qPCR or Western blotting, respectively. A representative blot was shown in (F).*P<0.05 compared to their respective controls. *P<0.05 or †P<0.001 compared to control.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 66

Metadata

Authors
Liu, T., Yu, H., Ullenbruch, M., Jin, H., Ito, T., Wu, Z., Liu, J., & Phan, S. H.
Affiliations
University of Michigan (US)
Corresponding author
Liu, Tianju
Venue
PLoS ONE
Published
2014-02-06
Volume
9
Issue
2
Pages
e88362
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2140869049
Cited by
62
References
50
Citations by year
2026: 1 · 2025: 5 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 6 · 2020: 7 · 2019: 6 · 2018: 8 · 2017: 7 · 2016: 5 · 2015: 7 · 2014: 1
FWCI
5.34
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health (HL-091775, DK020572)
  • Japan Society for the Promotion of Science (25860296)
  • National Heart, Lung, and Blood Institute (HL112880, R01HL112880, R37HL028737, HL-028737, P01HL091775, HL052285, R01HL028737, HL091775, R01HL052285)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK020572, P60DK020572, P30DK020572)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Keywords
Fizz1, pulmonary fibrosis, bleomycin-induced lung fibrosis, fibroblast activation, myofibroblast differentiation, dendritic cells, chemotaxis, inflammatory cytokines, chemokines, alveolar type II cells, airway inflammation
MeSH terms
Adenoviridae, Animals, Bleomycin, Bone Marrow Cells, Cell Differentiation, Hydroxyproline, Macrophages, Mice, Inbred C57BL, Pulmonary Fibrosis, Granulocyte-Macrophage Colony-Stimulating Factor, Cytokines, Mice, Knockout, Intercellular Signaling Peptides and Proteins, Green Fluorescent Proteins, Rats, Myofibroblasts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.